MellingMedical was recently awarded a Federal Supply Schedule 65IB Drugs, Pharmaceuticals and Hematology Related Products (Contract Number 36F79718D0378). This contract provides 72 pharmaceutical products needed to improve care at Veterans Administration (VA) Medical Centers, VA Consolidated Mail Outpatient Pharmacies (CMOPs), Defense (DoD) Medical Centers and other government health agencies.
“We are honored to provide better access to cost-effective pharmaceutical products to the Department of Veterans Affairs serving our Veterans,” said Christopher Melling, CEO and founder, a Desert Storm Navy veteran. “As a veteran-owned small business, we’re committed to improving the care available to those who serve our country.”
MellingMedical holds a Medical Equipment and Surgical Supply Schedule (Med/Surg), as well as a Pharmaceutical Schedule, and currently serves more than 160 VA Medical Centers, all seven VA CMOPs, 95 DoD Medical Facilities and Health and Human Services (HHS), including Indian Health Services (IHS) and the Center for Disease Control (CDC). MellingMedical provides access to innovative and cost-effective healthcare solutions in ophthalmology, optometry, wound care and diabetes management, urology and post-traumatic stress, in addition to a full range of pharmaceutical products through partnership with more than 50 recognized quality manufacturing partners.